{
    "code": "02024951",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024951",
    "time": "2018-03-09 03:03:00",
    "許可證字號": "衛署藥輸字第024951號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/12\/26",
    "發證日期": "97\/12\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "null",
    "中文品名": "舒倍生 2 毫克",
    "英文品名": "Suboxone 2 mg",
    "適應症": "鴉片類物質成癮之替代療法。",
    "劑型": "118舌下錠",
    "包裝": "12~1000錠 (CR AL-AL BLISTER)鋁箔盒裝 12~1000錠(PVC\/PVAC\/ACRYLATE LIDDING FOIL)鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "BUPRENORPHINEHYDROCHLORIDE,NALOXONEHCLDIHYDRATE"
    ],
    "限制項目": "02輸　入 33第三級管制藥品 58依本署891212衛署藥字第0890035812號公告經本署認定得免除國內銜接性試驗且經本署核定之新藥",
    "申請商名稱": "1225201100  裕利股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F130089000  RECKITT BENCKISER HEALTHCARE (UK) LIMITED",
        "製造廠廠址": "DANSOM LANE, HULL, EAST YORKSHIRE, UNITED KINGDOM, HU8 7DS",
        "製造廠公司地址": "103-105 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3UH, ENGLAND"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808801510",
            "成分名稱": "BUPRENORPHINE HYDROCHLORIDE",
            "含量描述": "",
            "含量": "2.1600000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2810000120",
            "成分名稱": "NALOXONE HCL DIHYDRATE",
            "含量描述": "",
            "含量": "0.6100000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Proposed Suboxone PI (第二階段)-107-01-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024951&Seq=003&Type=9"
        },
        {
            "title": "Suboxone Tab_2mgCarton Artwork-104-09-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024951&Seq=006&Type=8"
        }
    ]
}